PHYSIOLOGICAL DISPOSITION OF 5-METHOXYTRYPTAMINE AND ROPE CLIMBING PERFORMANCE OF RATS

被引:21
作者
VOGEL, WH
机构
[1] Department of Pharmacology, Jefferson Medical College, Philadelphia, Pennsylvania
来源
PSYCHOPHARMACOLOGIA | 1969年 / 15卷 / 02期
关键词
5-Methoxytryptamine; Animal Behavior; Drug Disposition; Psychotomimetic Compounds;
D O I
10.1007/BF00407040
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
5-Methoxytryptamine (5-MT) is taken up rapidly by rat tissues after IP injection (50 mg/kg) and the following peak levels (μg/g or ml of sample) were observed after 5 min: plasma, 5.3; liver, 126; skeletal muscle, 2.4; brain 0.43. Over 90% of the compound disappeared from the plasma and the tissues studied within 60 min. The compound impaired rope climbing performance of trained rats. Pretreatment of the animals with iproniazid enhanced the effect of 5-MT whereas its main (and probably only) metabolite, 5-methoxyindoleacetic acid, did not interfere with rope climbing at a dose of 75 mg/kg. 5-MT also produced marked cutaneous vasodilatation, analgesia and hindleg paralysis. All pharmacological effects lasted approximately 75 min. It is suggested that 5-MT is the pharmacological active agent and that behavioral changes observed after IP injection of the compound are mainly caused by the peripheral and little, if any, by a central action of this compound. © 1969 Springer-Verlag.
引用
收藏
页码:88 / &
相关论文
共 22 条
[1]  
AXELROD J, 1961, J BIOL CHEM, V236, P211
[2]  
BERTACCINI G, 1967, FARMACOL, V22, P230
[3]  
BRODIE BB, 1945, J BIOL CHEM, V158, P705
[4]   PASSAGE OF 5-HYDROXYTRYPTAMINE THROUGH BLOOD-BRAIN BARRIER ITS METABOLISM IN BRAIN AND ELIMINATION OF 5-HYDROXYINDOLEACETIC ACID FROM BRAIN TISSUE [J].
BULAT, M ;
SUPEK, Z .
JOURNAL OF NEUROCHEMISTRY, 1968, 15 (05) :383-&
[5]   PHARMACOLOGICAL STUDIES UPON NEURONES OF LATERAL GENICULATE NUCLEUS OF CAT [J].
CURTIS, DR ;
DAVIS, R .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1962, 18 (02) :217-&
[6]   KONSTITUTIONSCHEMISCHE BEDINGUNGEN FUR DIE WIRKSAMKEIT VON OXYTRYPTAMINDERIVATEN IM STRAHLENSCHUTZVERSUCH [J].
DUKOR, P ;
SCHUPPLI, R .
EXPERIENTIA, 1961, 17 (06) :257-&
[7]  
ERSPAMER V., 1952, RICERCA SCI, V22, P694
[8]  
ERSPAMER V, 1953, ARCH INT PHARMACOD T, V93, P177
[9]  
ERSPAMER V, 1951, EXPERIENTIA BASEL, V6, P428
[10]  
ERSPAMER VITTORIO, 1966, HANDBUCH EXP PHARMAKOL, V19, P245